Assessment of timing of transplacental antibody transfer after SARS-CoV-2 vaccination against the Omicron variant: A prospective cohort study
preprint
OA: closed
Abstract
Objective: To determine the optimal timing of SARS-CoV-2 vaccination during pregnancy by investigating the transplacental transfer of SARS-CoV-2 antibodies from maternal SARS-CoV-2 vaccination or infection. Design: Prospective cohort study Setting: Samples were collected between June 6, 2022 and September 20, 2022 in Taiwan. Sample Seventy-five maternal-cord pairs, including 38 pairs with a primary maternal SARS-CoV-2 infection by the Omicron variant (BA.2.3.7) and 37 pairs without maternal infection. Methods: SARS-CoV-2 antibodies against the nucleocapsid (anti-N), receptor-binding domain of the spike protein (anti-S), and the neutralizing antibody (nAb) titers against different SARS-CoV-2 variants were measured for the maternal-cord pairs. The participants were categorized based on the timing of their last vaccination, including during the third (T3) and second trimesters (T2) and before/during the first trimester (T1). Comparison of anti-spike protein antibody and neutralizing antibody concentrations was analyzed using the Kruskal-Wallis test followed by a post-hoc Mann-Whitney U test. Main Outcome Measures Anti-S concentrations of maternal and cord serum among T1, T2, and T3 groups. Results: Among participants without SARS-CoV-2 infection, the highest anti-S levels ( p value for anti-S levels in maternal and cord plasma were <0.001 and <0.001, respectively) and highest nAb potency against both the Wuhan and Omicron strains ( p value for nAb against Omicron strain were both <0.001 for maternal and cord plasma) were observed in maternal and cord plasma in the T3 group. Conclusions: A booster vaccine dose during the third trimester can provide maximum transplacental protection against the Wuhan wild-type strain and Omicron variant. Pregnant women are encouraged to receive vaccinations during pregnancy, ideally in the third trimester, for the highest level of neonatal protection.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00